LEA LEIV
SEC CIK 939012 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRVS | Corvus Pharmaceuticals, Inc. | CFO | 129.2K | $102.6K | — | 2 | 2022-03-16 | 2022-12-13 |
Most active insiders at CRVS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Moore David Scott | Dir | $250.2K | — |
| 2 | MILLER RICHARD A MD | Pres, CEO, Dir | $83.5K | — |
| 3 | Thompson Peter A. | Dir, 10% | — | — |
LEA LEIV made no open-market trades at CRVS in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2022-12-15 | 2022-12-13+ | CRVS | Corvus Pharmaceuticals, Inc. | LEA LEIV | CFO | P - Purchase | $0.7518 | +34.0K | 129.2K | +36% | +$25.6K |
| MI | 2022-03-17 | 2022-03-16+ | CRVS | Corvus Pharmaceuticals, Inc. | LEA LEIV | CFO | P - Purchase | $1.57 | +49.0K | 85.4K | +135% | +$77.0K |
Purchase Sale Sale after option exercise All abbreviations